India’s pharmaceutical industry supplies roughly 40 percent of the United States’ generic medicines and approximately 20 percent of global demand. Yet behind this impressive export footprint lies a structural vulnerability…
June 2026 marks a pivotal moment for India's generic pharmaceutical industry. From landmark shifts toward women's health therapeutics to explosive growth in the generic GLP-1 market and sweeping drug-quality reforms,…
One of the most common questions international buyers ask about Indian generic medicines is: "Are they really as effective as the original branded drug?" The answer lies in a rigorous…
Indian pharmaceutical companies, long celebrated as the “pharmacy of the world” for their affordable generic medicines, are now charting a strategic course toward specialty drugs, biosimilars, and innovative therapies. This…